News Releases October 20, 2021 Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering Read more September 20, 2021 Ventyx Biosciences Announces Key Appointments and Closing of $51.0 Million Series B Convertible Preferred Stock Financing Round Read more First page « Previous page ‹ Page 1 Current page 2 Displaying 11 - 12 of 12
